Intimation for closure of trading window with effect from 1st July 2025 till 48 hours from the date of declaration of unaudited financial results for the quarter ended 30th June, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech Ltd has informed BSE that its trading window will remain closed for all Directors, Promoters, Key Managerial Personnel, and other Designated Persons along with their immediate relatives, starting Tuesday, 1st July 2025. The window will reopen 48 hours after the declaration of unaudited standalone and consolidated financial results for the quarter ended 30th June 2025. The exact board meeting date to approve these Q1 results will be communicated later. Additionally, PAN-level freezing of trading for designated persons on the NSDL depository portal will be activated from the 1st day of the month following the end of the quarter, as per SEBI and BSE guidelines.
This is a routine regulatory compliance intimation under SEBI's Insider Trading Regulations and does not involve any actual insider buying or selling of shares. Investors should note that Q1 FY26 results are expected in the coming weeks, which could be a catalyst for stock movement.